Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /524322
chevron_leftBack
Kabra Drugs Ltd. logo

Kabra Drugs Ltd.

524322
• BSE: 524322 • Delayed
24.84INR -0.3%
0.2629 USD
As of 19 June 2026, Kabra Drugs Ltd. has a market cap of $6.22M USD, ranking #43594 globally and #3690 in India. It ranks #3864 in the Healthcare sector, and #267 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
43594
Country Rank
3690
Sector Rank
3864
Industry Rank
267
Key Stats
Market Cap
$6.22MUSD
588.9M INR
Enterprise Value
$5.04MUSD
476.61M INR
Revenue (TTM)
$6.06MUSD
573.34M INR
EBITDA (TTM)
$390.8KUSD
36.93M INR
Net Income (TTM)
$454.08KUSD
42.96M INR
EBITDA Margin
6.4%
Profit Margin
7.5%
PE Ratio
12.2
PS Ratio
1.0
PB Ratio
2.3
EV/EBITDA
12.9
Company Profile
Country (HQ)
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nanjappan Aravind open_in_new
Employees
31
Founded
1989
Website
kabradrugs.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% -7.4% -3.6% -16% 29% 124%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
524322 (KABRADG)
Kabra Drugs Ltd
ISIN: INE323K01017
TV:
BSE: KABRADG
SA:
BOM: 524322
YF:
524322.BO
GF:
BOM: 524322
BA:
524322
MS:
XBOM: 524322
24.84 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Kabra Drugs Ltd.

Kabra Drugs Limited does not have significant operations. Previously, the company was engaged in permaculture manufacturing and trading of pharma related products. Kabra Drugs Limited was incorporated in 1989 and is based in Chennai, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
PE
Cipla Ltd.
CIPLA
$11.25B
1.06T INR
181K%
23.4
Lupin Ltd.
LUPIN
$11.13B
1.05T INR
179K%
22.7
Aurobindo Pharma Ltd.
AUROPHARMA
$8.53B
807.02B INR
137K%
23.1
Cohance Lifesciences Ltd.
SUVENPHAR
$1.89B
178.87B INR
30K%
199.0
Granules India Ltd.
GRANULES
$1.85B
174.85B INR
30K%
32.1
Viyash Scientific Ltd.
SEQUENT
$956.27M
90.48B INR
15K%
92.7
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
Teva Pharmaceutical Industries Ltd.
TEVA
$37.2B
108.92B ILS
598K%
24.2
Revolution Medicines, Inc.
RVMD
$29.56B
475K%
-
Zhejiang NHU Company Ltd.
002001
$15.88B
107.34B CNY
255K%
16.0
Haisco Pharmaceutical Group Co., Ltd.
002653
$9.11B
61.6B CNY
146K%
80.6
ABIVAX Société Anonyme
ABVX
$8.73B
7.57B EUR
140K%
-
Dong-E-E-Jiao Co., Ltd.
000423
$5.23B
35.33B CNY
84K%
20.0
chevron_leftBack